Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications.
about
Cyclosporine A for induction of remission in severe ulcerative colitisInflammatory bowel disease: perioperative pharmacological considerations.Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis.Surgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn's diseaseMethods to avoid infections in patients with inflammatory bowel disease.Review article: how and when to use ciclosporin in ulcerative colitis.Inflammatory bowel disease: the view of the surgeon.Review article: saving the colon in severe colitis - the case for medical therapy.Perioperative Considerations in Crohn Disease and Ulcerative Colitis.Therapeutic options in acute severe ulcerative colitis.Perioperative complications in inflammatory bowel disease.Cyclosporine in patients with severe steroid refractory ulcerative colitis in the era of infliximab. Review article.Prolonged preoperative hospital stay is a risk factor for complications after emergency colectomy for severe colitis.The positioning of colectomy in the treatment of ulcerative colitis in the era of biologic therapy.Management of severe ulcerative colitis.Systematic Review: Sequential Rescue Therapy in Severe Ulcerative Colitis: Do the Benefits Outweigh the Risks?Perioperative use of immunosuppressive medications in patients with Crohn's disease in the new "biological era".Surgical treatment of ulcerative colitis in the biologic therapy era.[Refractory inflammatory bowel disease: surgical challenges].Short-term outcome of infliximab and other medications on patients with inflammatory bowel disease undergoing ileostomy reversal.[Perioperative handling of immunosuppressive therapy].Perioperative Management of Patients with Inflammatory Rheumatic Diseases Undergoing Major Orthopaedic Surgery: A Practical Overview.
P2860
Q24245067-AB4DEBCB-4FCC-42A7-8563-D85E9DC391C8Q30502980-0E6A07E7-CC3D-4D0B-838D-6BD9220378B0Q33596959-2373E805-EA10-439B-A29E-13479B6DDF1AQ35687929-0B253E1E-081C-46CE-ABF2-5282AA595BC7Q36171733-732C365F-C122-4AF8-BBFA-B430E3BFC0CDQ36305931-418748A7-9717-480A-AD0F-DF90ED0970F1Q36440539-104A82D4-3FB9-4AAC-910C-BD9CF0A989C0Q36589437-C452E014-A741-408B-813A-1072AEA6035FQ36940448-AE314C1C-5A47-4E31-B973-E7FFE275ECCBQ37345935-84EF21EC-B657-475D-B457-223003250308Q37889836-BE16CADE-562D-4B9B-B0C3-978B4EE7C5AFQ38056526-CD0DD49C-338F-421D-AA52-577357207225Q38117907-3B961C45-9AE6-4E43-B293-F8AF452DA713Q38121000-B6E2DB9A-A7AB-493D-9F76-E2F04FD7FEA5Q38321528-473B51BE-0250-4EAC-9877-AA759374F0A8Q38404037-A1AC9407-7249-48FA-936C-9A42E660D65FQ38635824-C086D8F3-CFD2-480F-AF6D-29A56CC68E62Q42728456-85F3E1E2-3AFE-45D0-9118-BCF468850107Q43577963-DE259336-384C-42D3-A8C2-F261CAFDC55EQ44037625-6D1BB78B-3E1E-4346-AE67-9FC70C16FFA4Q49630842-5F4B49CD-CDF9-485F-8BCD-725584F9F98AQ52349399-CF38BF6B-044B-46B2-B011-131D78C34DDB
P2860
Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Cyclosporin for severe ulcerat ...... f perioperative complications.
@en
Cyclosporin for severe ulcerat ...... f perioperative complications.
@nl
type
label
Cyclosporin for severe ulcerat ...... f perioperative complications.
@en
Cyclosporin for severe ulcerat ...... f perioperative complications.
@nl
prefLabel
Cyclosporin for severe ulcerat ...... f perioperative complications.
@en
Cyclosporin for severe ulcerat ...... f perioperative complications.
@nl
P2093
P356
P1476
Cyclosporin for severe ulcerat ...... f perioperative complications.
@en
P2093
Kettlewell MG
Mortensen NJ
P2888
P304
P356
10.1007/BF02234594
P577
2001-10-01T00:00:00Z